Diabetes mellitus refers to a family of metabolic disorders that are characterized by elevated blood glucose concentrations, or hyperglycemia. The International Diabetes Federation estimated that in 2015 there were 415 million diabetes cases worldwide in the 20-79 year old age group and predicted that number to increase to 640 million by 2040. In the whitepaper you will uncover
- Predicting disease onset via clinical biomarkers
- Applying the SomaScan® Assay to accurately identify serum proteins associated with diabetic risk and outcome
- Other potential applications for the SomaScan Assay in diabetes research